In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression
- PMID: 1445812
- DOI: 10.1097/00002371-199210000-00012
In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression
Abstract
Based on the clinicopathological classification of distinct stages of tumor progression in the melanocytic system, we have investigated the in vitro growth patterns and requirements of normal melanocytes and melanocytes isolated from different lesions of melanoma progression. Normal melanocytes depend on a combination of insulin-like growth factor (IGF-I) or insulin, 12-O-tetradecanoyl phorbol-13-acetate (TPA), alpha-melanocyte stimulating hormone (alpha-MSH), and basic fibroblast growth factor (bFGF) for in vitro proliferation. Nevus cells display a reduced need for TPA and are largely independent of bFGF. Both melanocytes and nevus cells have a finite lifespan in vitro and show no spontaneous transformation, whereas melanoma cells can be grown indefinitely in vitro. Cells from primary melanomas require only IGF-I or insulin for continuous growth, and metastatic melanoma cells can proliferate in base medium without addition of any growth factors or proteins. This progressive growth autonomy is paralleled by an increased competence for endogenous growth factor production. Among these growth factors, bFGF and melanoma growth-stimulatory activity (MGSA) act in an autocrine fashion. Melanoma-derived growth factors without apparent autocrine function, such as platelet-derived growth factor A and B (PDGF-A and PDGF-B) and transforming growth factor-alpha (TGF-alpha), might still be important for melanoma growth by stimulating surrounding normal fibroblasts, endothelial cells, or keratinocytes to secrete growth-promoting factors. The significance of growth factors such as transforming growth factor-beta (TGF-beta) and melanoma-inhibiting activity II (MIA II), which have a potentially negative autocrine function, remains unknown. The successful propagation of melanocytic cells of all stages of melanoma progression has yielded valuable insight into the mechanisms of growth regulation and malignant transformation.
Similar articles
-
Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro.Adv Cancer Res. 1990;54:213-34. doi: 10.1016/s0065-230x(08)60812-x. Adv Cancer Res. 1990. PMID: 2404378 Review.
-
Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes.J Invest Dermatol. 1991 Jul;97(1):20-6. doi: 10.1111/1523-1747.ep12477822. J Invest Dermatol. 1991. PMID: 2056188
-
Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.J Cell Biochem. 1990 Dec;44(4):207-19. doi: 10.1002/jcb.240440403. J Cell Biochem. 1990. PMID: 2095366
-
Characteristics of cultured human melanocytes from different stages of tumor progression.Cancer Treat Res. 1988;43:3-16. doi: 10.1007/978-1-4613-1751-7_1. Cancer Treat Res. 1988. PMID: 2908575 Review.
-
Growth factor independence and growth regulatory pathways in human melanoma development.Cancer Metastasis Rev. 1993 Sep;12(3-4):219-26. doi: 10.1007/BF00665954. Cancer Metastasis Rev. 1993. PMID: 8281609 Review.
Cited by
-
Pre-clinical modeling of cutaneous melanoma.Nat Commun. 2020 Jun 5;11(1):2858. doi: 10.1038/s41467-020-15546-9. Nat Commun. 2020. PMID: 32504051 Free PMC article. Review.
-
Common Delayed Senescence of Melanocytes from Multiple Primary Melanoma Patients.J Invest Dermatol. 2017 Mar;137(3):766-768. doi: 10.1016/j.jid.2016.10.026. Epub 2016 Oct 29. J Invest Dermatol. 2017. PMID: 27845147 Free PMC article. No abstract available.
-
Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.Oncotarget. 2017 Apr 18;8(16):26471-26491. doi: 10.18632/oncotarget.15594. Oncotarget. 2017. PMID: 28460440 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical